|Articles|November 1, 2007

Management and Treatment of Insomnia and Its Impact on Todayâ€™s Managed Care
Volume 13
Issue 5 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

almost 19 years ago

Article

Circadian Rhythmicity and the Pharmacologic Management of Insomnia

almost 19 years ago

Article

The State of Insomnia and Emerging Trends

almost 19 years ago

Article

Chronic Insomnia Treatment and Medicare Part D: Implications for Managed Care Organizations

almost 19 years ago

Article

Current Landscape of Insomnia in Managed Care

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Participating Faculty

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Infection Remains a Major Burden in Blood Cancers

Lilly Expands Retatrutide Access Amid Doctor Pushback

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Participating Faculty

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Infection Remains a Major Burden in Blood Cancers

Lilly Expands Retatrutide Access Amid Doctor Pushback

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk